These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35620641)

  • 1. A comparative analysis of attitudes toward stem cell research and regenerative medicine between six countries - A pilot study.
    Shineha R; Inoue Y; Yashiro Y
    Regen Ther; 2022 Jun; 20():187-193. PubMed ID: 35620641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies.
    Azuma K; Yamanaka S
    Regen Ther; 2016 Jun; 4():36-47. PubMed ID: 31245486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Analysis of Attitudes on Communication Toward Stem Cell Research and Regenerative Medicine Between the Public and the Scientific Community.
    Shineha R; Inoue Y; Ikka T; Kishimoto A; Yashiro Y
    Stem Cells Transl Med; 2018 Feb; 7(2):251-257. PubMed ID: 29372590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Science communication in regenerative medicine: Implications for the role of academic society and science policy.
    Shineha R; Inoue Y; Ikka T; Kishimoto A; Yashiro Y
    Regen Ther; 2017 Dec; 7():89-97. PubMed ID: 30271857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical implications of regenerative medicine in orthopedics: an empirical study with surgeons and scientists in the field.
    Niemansburg SL; van Delden JJ; Oner FC; Dhert WJ; Bredenoord AL
    Spine J; 2014 Jun; 14(6):1029-35. PubMed ID: 24184644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familiarity and prudence of the Japanese public with research into induced pluripotent stem cells, and their desire for its proper regulation.
    Shineha R; Kawakami M; Kawakami K; Nagata M; Tada T; Kato K
    Stem Cell Rev Rep; 2010 Mar; 6(1):1-7. PubMed ID: 20091428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote Monitoring of Chronic Diseases: A Landscape Assessment of Policies in Four European Countries.
    Rojahn K; Laplante S; Sloand J; Main C; Ibrahim A; Wild J; Sturt N; Areteou T; Johnson KI
    PLoS One; 2016; 11(5):e0155738. PubMed ID: 27195764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative analysis of attitudes toward genome-edited food among Japanese public and scientific community.
    Shineha R; Takeda KF; Yamaguchi Y; Koizumi N
    PLoS One; 2024; 19(4):e0300107. PubMed ID: 38625915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for the comparative evaluation of pharmaceuticals.
    Zentner A; Velasco-Garrido M; Busse R
    GMS Health Technol Assess; 2005 Nov; 1():Doc09. PubMed ID: 21289930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promissory identities: Sociotechnical representations & innovation in regenerative medicine.
    Gardner J; Higham R; Faulkner A; Webster A
    Soc Sci Med; 2017 Feb; 174():70-78. PubMed ID: 28012432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory brokerage: Competitive advantage and regulation in the field of regenerative medicine.
    Sleeboom-Faulkner M
    Soc Stud Sci; 2019 Jun; 49(3):355-380. PubMed ID: 31185876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping international research output within ethical, legal, and social implications (ELSI) of assisted reproductive technologies.
    Alon I; Chebance Z; Massucci FA; Bounartzi T; Ravitsky V
    J Assist Reprod Genet; 2023 Sep; 40(9):2023-2043. PubMed ID: 37382788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Researching multiple publics through latent profile analysis: Similarities and differences in science and technology attitudes in China, Japan, South Korea and the United States.
    Pullman A; Chen MY; Zou D; Hives BA; Liu Y
    Public Underst Sci; 2019 Feb; 28(2):130-145. PubMed ID: 30070170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restrictions on monetary payments for human biological substances in Japan: The
    Inoue Y; Masui T; Harada K; Hong H; Kokado M
    Regen Ther; 2023 Jun; 23():1-7. PubMed ID: 36942032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ELSI practices in genomic research in East Asia: implications for research collaboration and public participation.
    Yoshizawa G; Ho CW; Zhu W; Hu C; Syukriani Y; Lee I; Kim H; Tsai DF; Minari J; Kato K
    Genome Med; 2014; 6(5):39. PubMed ID: 24944586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stem cell research and science and technology policy in Japan].
    Yashiro Y
    Nihon Rinsho; 2011 Dec; 69(12):2251-6. PubMed ID: 22242329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethics in musculoskeletal regenerative medicine; guidance in choosing the appropriate comparator in clinical trials.
    de Windt TS; Niemansburg SL; Vonk LA; van Delden JM; Roes KCB; Dhert WJA; Saris DBF; Bredenoord AL
    Osteoarthritis Cartilage; 2019 Jan; 27(1):34-40. PubMed ID: 30243948
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.